ROBERT L FINE CANCER RESEARCH

EIN: 134091033 501(c)(3) Medical Research

TENAFLY, NJ

Total Revenue
$213,311
Total Expenses
$271,210
Total Assets
$4,591,456
Net Assets
$4,591,456
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2012
Legal Domicile
NY
Principal Officer
DR BARRY FINE
Phone
9173191176
Tax Period
2018-01-01 to 2018-12-31

ROBERT L FINE CANCER RESEARCH, founded in 2012, is a small nonprofit in the Medical Research sector that reported $213K in total revenue in fiscal year 2018. Revenue surged 102% from the prior year, signaling strong growth momentum. Expenses of $271K exceeded revenue, resulting in a 27% operating deficit.

Mission

PLEASE SEE BELOW.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2018)

Revenue Breakdown

Contributions & Grants $0
Program Service Revenue $0
Investment Income $213,311
Other Revenue $0
TOTAL REVENUE $213,311

Expense Breakdown

Grants Paid $0
Salaries & Benefits $0
Fundraising Expenses $0
Program Expenses $271,210
Other Expenses $271,210
TOTAL EXPENSES $271,210

Year-over-Year Comparison

2018 2017 Change
Revenue $213,311 $105,431 +1.0%
Expenses $271,210 $21,386 +11.7%
Net Income $-57,899 $84,045 -1.7%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
3
Independent Members
3
Employees
2
Volunteers
3

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
3
$10,000
Total Directors
0
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
DR BARRY FINE DIRECTOR 10.00
Officer
$10,000 $0 $10,000
ABIGAIL FINE DIRECTOR 5.00
Officer
$0 $0 $0
DR ROBERT FINE DIRECTOR 10.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2018 $213,311 $271,210 $4,591,456 $-57,899
Explore More Nonprofits
→Top 100 Nonprofits in New Jersey →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare ROBERT L FINE CANCER RESEARCH with other nonprofits in New Jersey and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.